The EWS/FLI-1 fusion product promotes tumor angiogenesis by upregulating VEGF-A expression [34], and in our study, Fli-1 knockdown attenuated the expression of Ki-67, VEGF, and cyclin D1 proteins. The gene discussed is VEGFA; the disease is neoplasm.